A citation-based method for searching scientific literature

A Persson, S C Sim, S Virding, N Onishchenko, G Schulte, M Ingelman-Sundberg. Mol Psychiatry 2014
Times Cited: 37







List of co-cited articles
204 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Association between CYP2C19 polymorphism and depressive symptoms.
Sarah C Sim, Linn Nordin, Therese M-L Andersson, Susanne Virding, Marita Olsson, Nancy L Pedersen, Magnus Ingelman-Sundberg. Am J Med Genet B Neuropsychiatr Genet 2010
33
36

Xenobiotic-metabolizing enzymes and transporters in the normal human brain: regional and cellular mapping as a basis for putative roles in cerebral function.
Fabien Dutheil, Sandrine Dauchy, Monique Diry, Véronique Sazdovitch, Olivier Cloarec, Lucille Mellottée, Ivan Bièche, Magnus Ingelman-Sundberg, Jean-Pierre Flinois, Isabelle de Waziers,[...]. Drug Metab Dispos 2009
120
18

Genetic variation in CYP2D6 impacts neural activation during cognitive tasks in humans.
Julia C Stingl, Christine Esslinger, Heike Tost, Edda Bilek, Peter Kirsch, Barbara Ohmle, Roberto Viviani, Henrik Walter, Marcella Rietschel, Andreas Meyer-Lindenberg. Neuroimage 2012
26
23

Cytochrome P450 mediates dopamine formation in the brain in vivo.
Ewa Bromek, Anna Haduch, Krystyna Gołembiowska, Władysława A Daniel. J Neurochem 2011
51
16

Elevated CYP2C19 expression is associated with depressive symptoms and hippocampal homeostasis impairment.
M M Jukić, N Opel, J Ström, T Carrillo-Roa, S Miksys, M Novalen, A Renblom, S C Sim, E M Peñas-Lledó, P Courtet,[...]. Mol Psychiatry 2017
19
31

CYP2D6 in the brain: genotype effects on resting brain perfusion.
J Kirchheiner, A Seeringer, A L Godoy, B Ohmle, C Maier, P Beschoner, E-J Sim, R Viviani. Mol Psychiatry 2011
40
13

Cytochrome P450 enzymes in the brain: emerging evidence of biological significance.
Charmaine S Ferguson, Rachel F Tyndale. Trends Pharmacol Sci 2011
154
13

Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects.
Magnus Ingelman-Sundberg, Sarah C Sim, Alvin Gomez, Cristina Rodriguez-Antona. Pharmacol Ther 2007
772
13

Potential role of CYP2D6 in the central nervous system.
Jie Cheng, Yueying Zhen, Sharon Miksys, Diren Beyoğlu, Kristopher W Krausz, Rachel F Tyndale, Aiming Yu, Jeffrey R Idle, Frank J Gonzalez. Xenobiotica 2013
40
13



Regional and cellular expression of CYP2D6 in human brain: higher levels in alcoholics.
Sharon Miksys, Yushu Rao, Ewa Hoffmann, Deborah C Mash, Rachel F Tyndale. J Neurochem 2002
111
13

Induction of the drug metabolizing enzyme CYP2D in monkey brain by chronic nicotine treatment.
Amandeep Mann, Sharon Miksys, Anna Lee, Deborah C Mash, Rachel F Tyndale. Neuropharmacology 2008
60
13

Cytochrome P450-mediated drug metabolism in the brain.
Sharon Miksys, Rachel F Tyndale. J Psychiatry Neurosci 2013
86
13

CYP2D6 in the brain: impact on suicidality.
J C Stingl, R Viviani. Clin Pharmacol Ther 2011
28
14

Regeneration of serotonin from 5-methoxytryptamine by polymorphic human CYP2D6.
Ai-Ming Yu, Jeffrey R Idle, Linda G Byrd, Kristopher W Krausz, Adrian Küpfer, Frank J Gonzalez. Pharmacogenetics 2003
137
10

Dopamine formation from tyramine by CYP2D6.
T Hiroi, S Imaoka, Y Funae. Biochem Biophys Res Commun 1998
185
10

Drug-metabolizing cytochrome P450s in the brain.
Sharon L Miksys, Rachel F Tyndale. J Psychiatry Neurosci 2002
129
10


The endocannabinoid anandamide is a substrate for the human polymorphic cytochrome P450 2D6.
Natasha T Snider, Matthew J Sikora, Chitra Sridar, Thomas J Feuerstein, James M Rae, Paul F Hollenberg. J Pharmacol Exp Ther 2008
71
10


Debrisoquine hydroxylation polymorphism and personality.
L Bertilsson, C Alm, C De Las Carreras, J Widen, G Edman, D Schalling. Lancet 1989
96
10

Cytochrome P-450 activities in human and rat brain microsomes.
P Voirol, M Jonzier-Perey, F Porchet, M J Reymond, R C Janzer, C Bouras, H W Strobel, M Kosel, C B Eap, P Baumann. Brain Res 2000
61
10

Cytochrome P4502D4 in the brain: specific neuronal regulation by clozapine and toluene.
E Hedlund, A Wyss, T Kainu, M Backlund, C Köhler, M Pelto-Huikko, J A Gustafsson, M Warner. Mol Pharmacol 1996
48
10

Regional and cellular distribution of CYP2D subfamily members in rat brain.
S Miksys, Y Rao, E M Sellers, M Kwan, D Mendis, R F Tyndale. Xenobiotica 2000
62
10

A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants.
Sarah C Sim, Carl Risinger, Marja-Liisa Dahl, Eleni Aklillu, Magnus Christensen, Leif Bertilsson, Magnus Ingelman-Sundberg. Clin Pharmacol Ther 2006
527
10



Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response.
J Kirchheiner, K Nickchen, M Bauer, M-L Wong, J Licinio, I Roots, J Brockmöller. Mol Psychiatry 2004
497
8

High risk of lifetime history of suicide attempts among CYP2D6 ultrarapid metabolizers with eating disorders.
E M Peñas-Lledó, P Dorado, Z Agüera, M Gratacós, X Estivill, F Fernández-Aranda, A Llerena. Mol Psychiatry 2011
35
8

CYP2C19 variation and citalopram response.
David A Mrazek, Joanna M Biernacka, Dennis J O'Kane, John L Black, Julie M Cunningham, Maureen S Drews, Karen A Snyder, Susanna R Stevens, Augustus John Rush, Richard M Weinshilboum. Pharmacogenet Genomics 2011
96
8

Genetic polymorphisms of cytochrome P450 enzymes influence metabolism of the antidepressant escitalopram and treatment response.
Ming-Hsien Tsai, Keh-Ming Lin, Mei-Chun Hsiao, Winston W Shen, Mong-Liang Lu, Hwa-Sheng Tang, Chun-Kai Fang, Chi-Shin Wu, Shao-Chun Lu, Shu Chih Liu,[...]. Pharmacogenomics 2010
79
8

Impact of the ultrarapid CYP2C19*17 allele on serum concentration of escitalopram in psychiatric patients.
I Rudberg, B Mohebi, M Hermann, H Refsum, E Molden. Clin Pharmacol Ther 2008
147
8

CYP2D6 genotype: impact on adverse effects and nonresponse during treatment with antidepressants-a pilot study.
Thomas Rau, Gerlinde Wohlleben, Henrike Wuttke, Norbert Thuerauf, Jens Lunkenheimer, Mario Lanczik, Thomas Eschenhagen. Clin Pharmacol Ther 2004
147
8

Constitutive expression and localization of the major drug metabolizing enzyme, cytochrome P4502D in human brain.
Shankar J Chinta, Harish V Pai, Sudarshan C Upadhya, Michael R Boyd, Vijayalakshmi Ravindranath. Brain Res Mol Brain Res 2002
59
8

Cellular localization and regional distribution of CYP2D6 mRNA and protein expression in human brain.
I Siegle, P Fritz, K Eckhardt, U M Zanger, M Eichelbaum. Pharmacogenetics 2001
113
8


Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes.
Rongrong Jiang, Satoshi Yamaori, Shuso Takeda, Ikuo Yamamoto, Kazuhito Watanabe. Life Sci 2011
142
8

Endocannabinoids regulate interneuron migration and morphogenesis by transactivating the TrkB receptor.
Paul Berghuis, Marton B Dobszay, Xinyu Wang, Sabrina Spano, Fernanda Ledda, Kyle M Sousa, Gunnar Schulte, Patrik Ernfors, Ken Mackie, Gustavo Paratcha,[...]. Proc Natl Acad Sci U S A 2005
198
8

Relation between CYP2D6 phenotype and genotype and personality in healthy volunteers.
Idilio González, Eva M Peñas-Lledó, Bárbaro Pérez, Pedro Dorado, Mayra Alvarez, Adrián LLerena. Pharmacogenomics 2008
58
8

The positive and negative syndrome scale (PANSS) for schizophrenia.
S R Kay, A Fiszbein, L A Opler. Schizophr Bull 1987
8


CYP2D6 polymorphism, pesticide exposure, and Parkinson's disease.
Alexis Elbaz, Clotilde Levecque, Jacqueline Clavel, Jean-Sébastien Vidal, Florence Richard, Philippe Amouyel, Annick Alpérovitch, Marie-Christine Chartier-Harlin, Christophe Tzourio. Ann Neurol 2004
135
8

Ethanol self-administration and nicotine treatment induce brain levels of CYP2B6 and CYP2E1 in African green monkeys.
Charmaine S Ferguson, Sharon Miksys, Roberta M Palmour, Rachel F Tyndale. Neuropharmacology 2013
19
15

Anti-epileptic drug phenytoin enhances androgen metabolism and androgen receptor expression in murine hippocampus.
Ralf Peter Meyer, Christoph Eugen Hagemeyer, Rolf Knoth, Michel Rene Kaufmann, Benedikt Volk. J Neurochem 2006
26
11

First demonstration that brain CYP2D-mediated opiate metabolic activation alters analgesia in vivo.
Kaidi Zhou, Jibran Y Khokhar, Bin Zhao, Rachel F Tyndale. Biochem Pharmacol 2013
32
9





Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.